乐观
$5.83
情景价格
$14.800
-0.759 (-5.13%)收盘时
Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.
Paysign Inc is a good buy right now, with a current price of $14.8 and a forward P/E ratio of 29.59, suggesting it is reasonably valued compared to its growth prospects. The company reported a Q2 EPS of $0.11, exceeding expectations by $0.05, and has a gross margin of 55.07% in Q2 2026, indicating strong profitability. However, the main risk is the recent 5-day price change of -3.71%, which reflects some short-term volatility.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Paysign to Discuss Q3 2026 Earnings on November 9

Paysign Reports Record Q2 Earnings, Raises Full-Year Guidance

Paysign Q2 Earnings Exceed Expectations

Global X Announces July 2026 ETF Distributions

Paysign to Discuss Q2 2026 Earnings on August 5
Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers. It operates in the Industrials sector (SERVICES-BUSINESS SERVICES, NEC industry).
Paysign Inc is a good buy right now, with a current price of $14.8 and a forward P/E ratio of 29.59, suggesting it is reasonably valued compared to its growth prospects. The company reported a Q2 EPS of $0.11, exceeding expectations by $0.05, and has a gross margin of 55.07% in Q2 2026, indicating strong profitability. However, the main risk is the recent 5-day price change of -3.71%, which reflects some short-term volatility.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。